MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme.
Future Oncol
; 14(8): 699-707, 2018 Apr.
Article
in En
| MEDLINE
| ID: mdl-29521523
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prognosis
/
DNA Modification Methylases
/
Glioblastoma
/
DNA Methylation
/
Tumor Suppressor Proteins
/
DNA Repair Enzymes
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Future Oncol
Year:
2018
Type:
Article
Affiliation country:
Italy